Patients getting gender-affirming operations nearly tripled in recent years. States are limiting these surgeries for minors, though few have them.
Author: Ken Alltucker, USA TODAY
Henrietta Lacks’ family settles lawsuit over use of HeLa cells to advance medical research
The lawsuit demanded the family be paid for the company’s use of Henrietta Lacks’ cells, which were taken without consent in the 1950s and used in research.
Eli Lilly’s donanemab slows early stages of Alzheimer’s disease, study shows
The data published Monday in the Journal of the American Medical Association found the drug donanemab slowed decline by 35% compared to placebo.
A child dies every 6 days amid custody fights, family court lapses. Advocates want change.
The California nonprofit Center for Judicial Excellence report finds family courts often miss signs of trouble and put children in harm’s way.
Esai and Biogen, Leqembi manufacturer, receive FDA approval for Alzheimer’s drug
Eisai and Biogen’s drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA’s full review.
Fourth of July fireworks come as some parts of US are ‘primed to burn’
Experts warn hot, dry conditions are ripe for wildfires ahead of Fourth of July celebrations. Some cities turn to drone light displays to curb risk.
Drugmaker Merck sues the Biden administration over Medicare’s drug price negotiations
Merck said the price negotiations are a ‘sham’ that compel drugmakers to accept lower prices, according to a lawsuit.
FDA seeks to ease cancer drug shortage with China-made imports
More than one dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin. U.S. eases import restrictions.
Doctors and patients are worried this large health insurer’s new policy will delay care
Doctors are raising concerns about UnitedHealthcare’s policy to require authorization before some colonoscopies and cancer scopes.
How the US reports COVID data is about to change. Here’s what you need to know.
As the public health emergency ends May 11, the CDC will change how it reports COVID data and will no longer be counting every case.